#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Chordoma Ornithine transcarbamoylase deficiency Adenomatous polyposis coli Soft tissue necrosis Human papilloma virus immunisation Pancreatic carcinoma Bone marrow disorder Pituitary-dependent Cushing's syndrome Primary mediastinal large B-cell lymphoma Cholangiosarcoma Langerhans' cell histiocytosis Precursor T-lymphoblastic lymphoma/leukaemia recurrent Thymic carcinoma Acute myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Trials in Disease Rhabdoid tumour – Life with Disease Cystic fibrosis lung – Life with Disease Primary biliary cholangitis – Life with Disease Mucous membrane pemphigoid – Treatment Ocular melanoma Mantle cell lymphoma stage IV – Diagnostics Noonan syndrome – Diagnostics Myelodysplastic syndrome Advanced systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Seralutinib Biotin AAV9-CTNT-COBAG3 Sodium Picosulfate Atropine Sulfate Monohydrate Temocillin Fluvastatin Tretinoin Betula Alba Pollen Extract Vatiquinone Roxadustat Efinopegdutide Vancomycin Hydrochloride Pc14586 Sonidegib Prasinezumab AB521 Medi0618 Salbutamol Sulfate Ph. Eur. Calcium More therapies…

    Learn about Your Condition

    Post procedural complication Diabetic nephropathy Neurogenic bladder Generalised anxiety disorder Rasmussen encephalitis Staphylococcal bacteraemia Osteopenia Hairy cell leukaemia Marfan's syndrome Large cell lung cancer Breast proliferative changes Mesothelioma Cholangitis sclerosing Stargardt's disease Exfoliation glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Durvalumab
    • Infliximab
    • Mycophenolate Mofetil
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    • Tirzepatide
    • Mirikizumab
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

    Recruiting

    3 1
    Belgium Bulgaria France Germany Greece Italy +4

  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Recruiting

    2 1
    Investigated Diseases:
    • Vitiligo
    France Germany Italy The Netherlands Spain

  • Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

    Recruiting

    3 1 1
    Investigated Drugs:
    • Remibrutinib
    Bulgaria Czechia France Germany Poland Spain

  • Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Durvalumab
    France Italy The Netherlands Spain

  • Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

    Recruiting

    3 1
    Belgium Czechia France Germany Hungary Italy +3

  • Treatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute promyelocytic leukaemia
    Investigated Drugs:
    • Arsenic Trioxide
    • Methylprednisolone Sodium Succinate
    • Gemtuzumab Ozogamicin
    Czechia France Italy The Netherlands Sweden
1 2 3 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!